Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is associated with a high risk of mortality and frequent hospitalization. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have favorable cardiovascular protective effect and could decrease the risk of mortality and hospitalization...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hufang, Peng, Wenhua, Li, Fuyao, Wang, Yuelin, Wang, Baofu, Ding, Yukun, Lin, Qian, Zhao, Ying, Pan, Guozhong, Wang, Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116195/
https://www.ncbi.nlm.nih.gov/pubmed/35600478
http://dx.doi.org/10.3389/fcvm.2022.875327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116195/
https://www.ncbi.nlm.nih.gov/pubmed/35600478
http://dx.doi.org/10.3389/fcvm.2022.875327

Ejemplares similares